CAMP4 Therapeutics Corporation ( CAMP) - Key Metrics
CAMP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.07 | -$0.62 | -$0.51 | -$0.51 |
| 2025Q4 | $0.04 | -$0.64 | -$0.73 | -$0.75 |
CAMP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -0.58 |
| 2025Q4 | ? | -1.57 |
CAMP Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -4.30% | ? |
| 2025Q4 | 1.98% | ? |
| 2025Q3 | -18.55% | ? |
| 2025Q2 | -35.38% | ? |
| 2025Q4 | -18.67% | ? |
CAMP
Price: $4.13
52 week price:
Earnings Per Share: -2.35 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 144300
Ebitda: 23.8 millionMarket Capitalization: 87.3 million